ELTX ELICIO THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Interim Data Announcement Elicio Therapeutics announced positive interim data from a Phase 1 study of ELI-002 at ASCO annual meeting.Get access to all SEC 8-K filings of the ELICIO THERAPEUTICS INC